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Results

Hereditary Tyrosinemia Type 1 (HT1) is a genetic disorder resulting from
a mutation in the fumarylacetoacetate hydrolase (FAH) gene, producing
a dysfunctional enzyme for the metabolism of tyrosine. This causes a
build-up of tyrosine and other metabolites in the organs and tissues,
harming the kidneys, liver, and brain. Currently the only drug on the
market is Orfadin (NTBC).1
A mouse model of HT1 was used to test social and cognitive function.
Diseased mice taking NTBC were compared with healthy mice taking
NTBC and diseased mice not taking the drug. Independently of NTBC
treatment, mice with HT1 showed reduced learning and ability to
adapt.2,3
Eight key metabolites in the HT1 mouse urine have been identified.
Current work is in developing a metabolomics protocol for analyzing the
mouse urine components using NMR and LC-MS.
The difficulty in this project arises from the complexity of the mixture.
Metabolomics databases contain approximately 75,000 different
metabolites and identifying individual components requires careful
experimental design and execution.4 Beyond this metabolites are in an
aqueous solution, which by itself is a challenge. Further complications
arise from the inherently low concentrations of individual components.

•

A spectrum of artificial mouse urine was compared with a spectrum of
mouse urine. Differences in shielding and complexity are notable.

Figure 3: NMR spectrum of mouse urine compared with artificial urine.

Methods
•
•

•

NMR experiments were run on a Unity INOVA® Varian 500MHz NMR.
(H)PRESAT, PSYCHE, COSY, and HSQC experiments were used.
An NMR stack of individual components of synthetic mouse urine is
compared to a mixture in the figure below. Chemical interactions
between components in the mixture result in different peak positions
than for individual components. This helps in identifying peaks which are
shifted in the urine sample due to similar shielding effects.
LC-MS experiments were run on a Thermo Scientific Orbitrab XL®. LC-MS
allows for the detection of components at low concentrations.

Figure 4: LC-MS Calibration curve with hydroxyindoleacetic acid response.

Conclusions
•

•

•

A database of metabolites was drafted and a protocol for NMR and MS
analysis of neurotransmitters and amino acids in mixtures developed. The
NMR and MS detection limits for the eight key metabolites were also
determined.
Problems encountered included lack of sensitivity and overlap between
peaks in the NMR spectrum. This was somewhat overcome by using
multiple methods of analysis—NMR and LC-MS—and analyzing data with
both VNMRJ® and MestreNova® software. 2D NMR experiments will be
used in future work to minimize peak overlap.
Further work includes building the database of metabolites, refining the
metabolomic protocol, obtaining fresh mouse urine samples and analyzing
them under standard conditions.
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